When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOLD - Amicus Therapeutics: Looking A Few Years Ahead
Amicus Therapeutics Inc.
Amicus Therapeutics (FOLD) has significantly transformed over the last few years. From a company with an uncertain regulatory status of its lead product (Galafold) and a young and not too diversified pipeline to a company with substantial evidence of strong commercial capabilities and a significantly expanded pipeline. Yes, there were setbacks along the way, but the changes to the thesis were (very) net positive. Amicus is one of the typical biopharma stocks I want to own:
One with a capable and bold management team (their achievements and qualities are summarized in the points